| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/02/2004 | WO2004024084A3 Rb pahtway and chromatin remodeling genes that antagonize let-60 ras signaling |
| 09/02/2004 | WO2004022702A3 Methods and reagents for identifying inhibitors of viral protease activity. |
| 09/02/2004 | WO2004022657A3 Increasing of the resorption of substances via skin and mucous membranes |
| 09/02/2004 | WO2004020665A3 Diagnostic and therapeutic use of foap-13 polynucleotides and polypeptides for neurodegenerative diseases |
| 09/02/2004 | WO2004020596A3 Polypeptides for increasing mutant cftr channel activity |
| 09/02/2004 | WO2004018627A3 Methods for propagating adenovirus and virus produced thereby |
| 09/02/2004 | WO2004016212A3 Methods and compositions for targeting secretory lysosomes |
| 09/02/2004 | WO2004015079A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 09/02/2004 | WO2004015069A3 MP2153S AS MODIFIERS OF THE p21 OR p53 PATHWAY AND METHODS OF USE |
| 09/02/2004 | WO2004010101A3 Detection of chemical ligation using fluorescence quenching leaving groups |
| 09/02/2004 | WO2004008102A3 Liver tumor marker sequences |
| 09/02/2004 | WO2004001012A3 Plant defensins |
| 09/02/2004 | WO2003105763B1 Prevention and/or treatment of inflammatory bowel disease using pyy or agonists thereof |
| 09/02/2004 | WO2003095623A3 Genetically engineered cell lines and systems for propagating varicella zoster virus and methods of use thereof |
| 09/02/2004 | WO2003093817A3 Method of identifying ligands for nuclear receptors |
| 09/02/2004 | WO2003087156A3 Heterogeneous crosslinked protein networks and methods for producing them |
| 09/02/2004 | WO2003080799A3 Polymorphic repetitive sequences in chlamydiae and uses thereof |
| 09/02/2004 | WO2003070967A3 Highly homogeneous molecular markers for electrophoresis |
| 09/02/2004 | WO2003037933A3 Dermopharmaceutically and cosmetically active oligopeptides |
| 09/02/2004 | WO2003015697A3 Interleukin-2 mutants with reduced toxicity |
| 09/02/2004 | WO2003004689A3 Regulators of biofilm formation and uses thereof |
| 09/02/2004 | WO2003002717A3 Biological activity of ak155 |
| 09/02/2004 | WO2002072766A8 Induction of tumor immunity by variants of folate binding protein |
| 09/02/2004 | US20040172689 Recombination polypeptide for use as gene insertion tool during genic transfer; tissue engineering and the generaton of disease resistant plants |
| 09/02/2004 | US20040172688 Expression vector comprising nucleotide sequences coding internal protein fragments for use in transforming and controlling heteroolgous, tissue specific gene expression in plants |
| 09/02/2004 | US20040172687 Modified proteinase inhibitors |
| 09/02/2004 | US20040172686 Plant development regulating gene and its uses |
| 09/02/2004 | US20040172685 Method of using MAPK4 and orthologues thereof to control plant disease resistance and plant growth |
| 09/02/2004 | US20040172684 Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement |
| 09/02/2004 | US20040172683 Comprises cocoa flavor peptides for improving the preparation of cocoa flavor and cocoa flavor substitutes; food processing and flavor enhancement |
| 09/02/2004 | US20040172679 Monocotyledon plant cells and plants which synthesise modified starch |
| 09/02/2004 | US20040172676 Transforming cells with expression vector comprising early nodulin gene-2 (ENOD2) promoter for use as tissue specific gene regulatory tool; bioreactors and heterologous gene expression |
| 09/02/2004 | US20040172673 Expression vector comprising nucleotide sequences coding polypetide which confers resistance to pseudomonas syringae; genetic engineering and disease resistant plants |
| 09/02/2004 | US20040172671 Transformed dicotyledon comprising nucleotide sequences coding cercropin lytic toxin which prevents parasitic infection of root system |
| 09/02/2004 | US20040172670 Maize yellow stripe1 and related genes |
| 09/02/2004 | US20040172667 Administration of transposon-based vectors to reproductive organs |
| 09/02/2004 | US20040172666 Transgenic birds and method of producing protein using same |
| 09/02/2004 | US20040171825 Human fibroblast growth factor-related compositions |
| 09/02/2004 | US20040171823 Polynucleotides and polypeptides associated with the NF-kappaB pathway |
| 09/02/2004 | US20040171821 Nucleotide sequences coding salivary polypeptide for use in development of vaccines for prevention and treatment of leishmanaisis; antiprotozoa agents; parsiticides |
| 09/02/2004 | US20040171816 Humanized antibodies that recognize beta amyloid peptide |
| 09/02/2004 | US20040171815 treatment of diseases associated with amyloid deposits in the brain (pre-clinical Alzheimer's disease or Down's syndrome); genetic engineering |
| 09/02/2004 | US20040171813 comprises homogenizing to produce a green juice, adjusting pH and heating, separating by centrifugation and/or resuspension, then chromatography |
| 09/02/2004 | US20040171812 found in natural rubber that can induce an allergic reaction in persons who have been sensitised to it; for determining molecular weight, isoelectric point, amino acid sequence and allergenicity; for immunoassay/therapy |
| 09/02/2004 | US20040171811 for drug screening using animal models with in vitro activation; genetic engineering |
| 09/02/2004 | US20040171810 used to find a novel protein linked to the cytomatrix and considered to play an important role in synaptogenesis |
| 09/02/2004 | US20040171809 BH3 peptides and method of use thereof |
| 09/02/2004 | US20040171807 involves engineering a recombinant shuttle vector comprising a nucleic acid cassette encoding prokaryotic green fluorescent protein (GFP) operably linked to regulatory sequences which permit its expression in a host cell |
| 09/02/2004 | US20040171806 Modified hpv e6 and e7 genes and proteins useful for vaccination |
| 09/02/2004 | US20040171805 including prevention and treatment of microbial diseases, diagnostic assays for detecting infection; for drug screening vaccines; genetic engineering |
| 09/02/2004 | US20040171804 for drug screening cancer, osteoporosis, obesity, Alzheimer's disease drugs; genetic engineering; kits |
| 09/02/2004 | US20040171803 Artificial protein having potentiated immunogenicity of epitope |
| 09/02/2004 | US20040171802 Haemophilus influenzae antigens and corresponding dna fragments |
| 09/02/2004 | US20040171801 Nk-2 homeobox transcription factor |
| 09/02/2004 | US20040171800 Gamma retinoic acid receptor |
| 09/02/2004 | US20040171796 comprising an agonist of a majort histocompatability complex (MHC) class I binding native sequence having enhanced immunogenicity; for inhibiting or killing CEA epitope-expressing carcinoma cells; genetic engineering; kits |
| 09/02/2004 | US20040171795 capable of binding to a gene and transferring this gene into cells, have an affinity with phosphatidylserine, have a high safety and an excellent selectivity; for gene therapy/cancer treatment; genetic engineering |
| 09/02/2004 | US20040171794 Kunitz domain peptides |
| 09/02/2004 | US20040171793 Cyclic peptides as potent and selective melanocortin-4 receptors agonists |
| 09/02/2004 | US20040171574 Growth hormone and growth hormone releasing hormone compositions |
| 09/02/2004 | US20040171567 Method for detection of neoplastic cells |
| 09/02/2004 | US20040171554 Compositions and methods for enhancing apoptosis |
| 09/02/2004 | US20040171553 Peptides fragments of colostrinin and their use |
| 09/02/2004 | US20040171551 which binds to an amino acid sequence comprising at least 5 EP motifs over a 19 amino acid segment |
| 09/02/2004 | US20040171549 Method of inhibiting angiogenesis or invasion or formation of metastases |
| 09/02/2004 | US20040171547 inhibiting the growth of a cancerous cell by contacting cell with an effective amount of a RhoB protein, or a variant of the RhoB protein; alone or in combination with additional anti-cancer agents, such as cytotoxic agents (e.g., 5-flurouracil) |
| 09/02/2004 | US20040171546 Regulation of lung tissue by hedgehog-like polypeptides and formulations and uses related thereto |
| 09/02/2004 | US20040171542 T1249 is a member of a new class of antiviral agents that inhibit virus/membrane fusion |
| 09/02/2004 | US20040171541 combination comprising a polypeptide comprising the modulating sequence of the erythropoietin receptor and a non-peptide organic molecule in the treatment of anemia |
| 09/02/2004 | US20040171540 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr protein, and uses thereof |
| 09/02/2004 | US20040171538 Anticoagulants and their uses |
| 09/02/2004 | US20040171537 Adapter gene |
| 09/02/2004 | US20040171536 human immunodeficiency virus inhibiting protein (HIVIP) isolated from poisonous snake Australian taipan |
| 09/02/2004 | US20040171534 chimeric analogs include a hydrophobic moiety (tail), and can be prepared, either by anchoring one or several hydrophobic tails to the GRF, or by substituting one or several amino-acids by a pseudomicellar residue in the chemical synthesis of GRF |
| 09/02/2004 | US20040171530 Polypeptides containing cysteine and tryptophan |
| 09/02/2004 | US20040171529 Treatment with neurotrophic factors |
| 09/02/2004 | US20040171523 Immunogenic glycopeptides, screening, preparation and uses |
| 09/02/2004 | US20040171159 Cell-specific adenovirus vector comprising EBV-specific promoter |
| 09/02/2004 | US20040171158 Adenoviral vector incorporating zipper peptide-modified fiber protein and uses thereof |
| 09/02/2004 | US20040171155 Materials and methods for management of hyperacute rejection in human xenotransplantation |
| 09/02/2004 | US20040171149 Oligonucleotides for controlling growth factor expression and treatment of cell proliferative and skin disorders; antisense agents |
| 09/02/2004 | US20040171133 Transgenic microorganism comprising defective acyltransferase nucleotide sequences and reduced lipooligosaccharide (LOS) concentrations in membranes for prevention, diagnosis and treatment of meningococcal infections; genetic vaccines |
| 09/02/2004 | US20040171132 Comprises nucleotide sequences coding herpes virus glycoprotein for developing vaccine which prevents respiratory system disorders in poulty; veterinary medicine; genetic vaccines |
| 09/02/2004 | US20040171123 fusion protein of an antibody that binds to human epidermal growth factor receptor-2 (HER2) and albumin with long shelf-life; stabilizing therapeutic proteins such as antibodies by conjugating them to albumin |
| 09/02/2004 | US20040171121 Methods for preparing Bacillus anthracis sporulation deficient mutants and for producing recombinant Bacillus anthracis protective antigen for use in vaccines |
| 09/02/2004 | US20040171120 Enhanced insecticidal protein for killing bettles, moths, flies; biolgical pest control |
| 09/02/2004 | US20040171116 Recombinant protein variants |
| 09/02/2004 | US20040171115 Comprises hematopoietic protein modulator for use in proliferation and diffefrentiation of bone marrow cells |
| 09/02/2004 | US20040171114 Isolation and use of ryanodine receptors |
| 09/02/2004 | US20040171113 Antigens of group b streptococcus and corresponding dna fragments |
| 09/02/2004 | US20040171112 Used to determine the redox status within a cell for example; mutant has cysteine at specified positions |
| 09/02/2004 | US20040171111 Polypeptide of a p53 protein-specific murin a/t-cell receptor, nucleic acids coding therefor and use thereof |
| 09/02/2004 | US20040171109 Comprises nucleotide sequences coding interleukin receptor protein for use in the diagnosis, prevention and treatment of bone disorders; gene therapy |
| 09/02/2004 | US20040171108 Human excitatory amino acid transporter-2 gene promoter and uses thereof |
| 09/02/2004 | US20040171107 Modified flourescent proteins |
| 09/02/2004 | US20040171105 Using enzymatic polypeptide to inactivate inhibitor of apoptosis and activate caspase for treatment and prevention of cancer, autoimmune and neurodegenerative diseases |
| 09/02/2004 | US20040171090 Screening for cytotoxic t-lymphocyte recognition antigen associated with human t-cell leukemia virus infected cells for diagnosing and prognosing inflammation and cell proliferation disorders |
| 09/02/2004 | US20040171082 Diagnostic method |
| 09/02/2004 | US20040171069 Kinetic assay |
| 09/02/2004 | US20040171067 Identifying modulators of g protein coupled receptor activity for diagnosing, treating and preventing disorders associated with cholesterol metabolism, cancer, infections and inflammation |